Multiple sclerosis and oligodendroglioma

Multiple Sclerosis

Volumn 7, Issue 4, 2001, Pages 269-273

  Green, A J ^a   Bollen, A W ^a   Berger, M S ^a   Oksenberg, J R ^a   Hauser, S L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glioma; Multiple sclerosis; Oligodendrocyte; Oligodendroglioma

Indexed keywords

CYTOKINE; GLUCOCORTICOID;

ADULT; ARTICLE; BENIGN TUMOR; CANCER TISSUE; CASE REPORT; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; IMMUNE DEFICIENCY; MITOSIS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; OLIGODENDROGLIOMA; ONSET AGE; RADIATION BEAM; REMISSION; REMYELINIZATION;

ADULT; AGE OF ONSET; BRAIN STEM NEOPLASMS; CEREBELLAR NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGODENDROGLIOMA;

EID: 0034882294     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801680209394     Document Type: Article

References (38)

1. Concurrence of multiple sclerosis and primary intracranial neoplasms
2. Coincidence of multiple sclerosis and glioma: Clinical and radiological remarks on two cases
3. Glioblastoma associated with multiple sclerosis: Coincidence or induction?
4. Multiple cerebral gliomas in MS
5. Combination of multiple sclerosis and cerebral glioblastoma
6. Diagnostic problems in MS: Two cases with clinical diagnosis of MS showing only a diffusely growing malignant astrocytoma
7. Multiple sclerosis and cerebral tumor
8. La 'glioblastomatose en plaques': Sur les limites anatomiques de la gliomatose et des processus sclerotiques progessifs
9. Classification
10. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
11. A cytogenetic study of 53 gliomas
12. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma
13. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
14. Multiple sclerosis
15. Concurrence of multiple sclerosis and brain tumor: Clinical considerations
16. Weekly clinicopathological conference: Case records of the Massachusetts General Hospital. Case 12-1997
17. The 5-year risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial
18. Multiple sclerosis with an associated diffuse oligodendroglioma
19. Multiple sclerosis. Genomic rewards
20. Concordant cerebral oligodendroglioma in identical twins
21. Clinical concordance in sibling pairs with multiple sclerosis
22. Clinical demographics of multiplex families with multiple sclerosis
23. Familial factors influence disability in MS multiplex families. French multiple sclerosis genetics group
24. Patterns of oligodendroglia pathology in multiple sclerosis
25. Oligodendrocytes in the early course of multiple sclerosis
26. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
27. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord
28. Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis: Implications for clinical trials
29. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system
30. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis
31. IL-10 production by adult human derived micro-glial cells
32. Association between multiple sclerosis and oligodendroglioma: Case report
33. Mixed glioma, multiple sclerosis, and Charcot-Marie tooth disease
34. Multiple sclerosis with amyotrophy complicated by oligodendroglioma. History of recurrent herpes zoster
35. Gliomatous transformation and demyelinating diseases